Back to Search
GEORGE WORTHEN, MD
MD
Internal Medicine Physician
NPI: 1699845123Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
26289(CO)
Research & Publications (20)
A novel method for long term bone marrow culture and genetic modification of murine neutrophils via retroviral transduction.
PMID 19010330·J Immunol Methods·2009
7-preclinical
Myeloid differentiation protein-2-dependent and -independent neutrophil accumulation during Escherichia coli pneumonia.
PMID 18988922·Am J Respir Cell Mol Biol·2009
7-preclinical
Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.
PMID 18292555·J Immunol·2008
7-preclinical
Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia.
PMID 17312163·J Immunol·2007
7-preclinical
Dual role for RhoA in suppression and induction of cytokines in the human neutrophil.
PMID 17018860·Blood·2007
8-other
Human lung project: evaluating variance of gene expression in the human lung.
PMID 16498083·Am J Respir Cell Mol Biol·2006
8-other
Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation.
PMID 17137798·Immunity·2006
7-preclinical
Systemic inhibition of the angiotensin-converting enzyme limits lipopolysaccharide-induced lung neutrophil recruitment through both bradykinin and angiotensin II-regulated pathways.
PMID 17082641·J Immunol·2006
7-preclinical
Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa.
PMID 16785551·J Immunol·2006
4-observational
Toll-IL-1 receptor domain-containing adaptor protein is critical for early lung immune responses against Escherichia coli lipopolysaccharide and viable Escherichia coli.
PMID 16301656·J Immunol·2005
7-preclinical
Regulation of lipopolysaccharide-induced lung inflammation by plasminogen activator Inhibitor-1 through a JNK-mediated pathway.
PMID 16148154·J Immunol·2005
7-preclinical
Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils.
PMID 15908399·Infect Immun·2005
8-other
Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium.
PMID 15778492·Am J Respir Cell Mol Biol·2005
7-preclinical
Inhibition of c-Jun N-terminal kinase limits lipopolysaccharide-induced pulmonary neutrophil influx.
PMID 15735060·Am J Respir Crit Care Med·2005
7-preclinical
Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury.
PMID 15731076·Infect Immun·2005
7-preclinical
A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense.
PMID 15591471·Am J Respir Crit Care Med·2005
7-preclinical
Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.
PMID 15117744·Am J Respir Crit Care Med·2004
8-other
Transcriptional profiling of lipopolysaccharide-induced acute lung injury.
PMID 15557650·Infect Immun·2004
7-preclinical
Lipid rafts regulate lipopolysaccharide-induced activation of Cdc42 and inflammatory functions of the human neutrophil.
PMID 15262974·J Biol Chem·2004
8-other
Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic inflammation.
PMID 15256385·Am J Respir Cell Mol Biol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1400 JACKSON ST
DENVER, CO 80206 - Phone
- (303) 388-4461
Quick Facts
- NPI
- 1699845123
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile